Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Clinical trial NCT05929664 · SUSPENDED

Trial details

NCT number: NCT05929664
Sponsor: Thomas Jefferson University
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Basal Cell Carcinoma Basal Cell Carcinoma

Start date: 2023-07-05
Primary completion: 2031-07-05
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.